Adderall XR Cost in Louisiana 2026: Cash Price, Medicaid, and Cheaper Alternatives

What Does Adderall XR Actually Cost in Louisiana Right Now?

Generic mixed amphetamine salts XR costs an average of $30 per month cash-pay at Louisiana retail pharmacies in 2026, while the brand-name Teva product carries a list price near $260 per month. The gap between those two numbers is wide enough that most patients who pay out of pocket have no reason to buy the brand. Manufacturer coupons, GoodRx-style discount programs, and 503A compounding can push that number lower still.

The $30 figure reflects a 30-day supply of a common dose (10 mg to 30 mg capsules) at chains such as CVS, Walgreens, Walmart, and independent Louisiana pharmacies. Prices shift by dose strength and quantity: a 30-count supply of 5 mg capsules may run closer to $18, while 30 mg capsules for the same count can reach $45 at some locations. Calling ahead to compare pharmacy-specific pricing in Baton Rouge, New Orleans, Shreveport, or Lafayette often yields a $5 to $15 difference for the identical product.

The Multimodal Treatment Study of Children with ADHD (the MTA Study, N=579), published in the Archives of General Psychiatry in 1999, established that stimulant pharmacotherapy produced superior ADHD symptom control compared with behavioral treatment alone at 14 months, which helped cement mixed amphetamine salts as a first-line agent. [1] That long treatment history means a strong generic market now exists, and generic competition is the single biggest reason Louisiana cash prices have fallen this decade.

A practical cost-comparison framework for Louisiana patients:

| Route | Estimated Monthly Cost | Notes | |---|---|---| | Brand Adderall XR (Teva) | ~$260 | List price, no coupon | | Generic mixed amphetamine salts XR | ~$30 | Cash-pay, major chain | | Generic + GoodRx or similar coupon | ~$18, $25 | Varies by pharmacy and dose | | 503A compounded mixed amphetamine salts | ~$0, $30 | Through licensed LA compounding Rx | | Louisiana Medicaid | Not covered | See section below |

Does Louisiana Medicaid Cover Adderall XR?

Louisiana Medicaid does not cover Adderall XR. The Louisiana Medicaid Preferred Drug List (PDL) excludes Adderall XR brand and, as of 2026 formulary guidance, does not include generic mixed amphetamine salts extended-release as a preferred agent without prior authorization. [2]

Patients enrolled in Louisiana Medicaid who carry an ADHD diagnosis can request a prior authorization (PA) for generic mixed amphetamine salts, but approval rates vary and the PA process requires documentation of ADHD diagnosis, prescriber specialty or referral, and in some cases a trial of a preferred stimulant such as methylphenidate. The Louisiana Department of Health publishes its current Medicaid PDL at ldh.la.gov; patients and prescribers should check that resource directly because drug-tier status changes quarterly.

Children enrolled in Louisiana CHIP (LaCHIP) face the same PDL constraints. Parents navigating the PA route should ask the prescribing clinician to submit a detailed clinical note, because denials are frequently overturned on appeal when the file includes standardized ADHD rating scales such as the Vanderbilt or Conners.

For patients who cannot get Medicaid coverage approved, the $30 cash-pay generic price is often comparable to or lower than the Medicaid cost-share for a brand drug, making the out-of-pocket generic route a reasonable fallback.

Is Compounded Mixed Amphetamine Salts Legal in Louisiana?

Compounded mixed amphetamine salts are legal in Louisiana when prepared by a state-licensed 503A compounding pharmacy operating under a valid patient-specific prescription from a licensed prescriber. [3]

Section 503A of the Federal Food, Drug, and Cosmetic Act permits licensed pharmacists to compound drugs for individual patients when a valid prescription exists. Louisiana Board of Pharmacy rules align with these federal standards, requiring that Schedule II compounded stimulants follow state Controlled Dangerous Substances (CDS) regulations, including separate DEA registration for the pharmacy and prescriber.

A few practical points for Louisiana patients:

The compounded product is patient-specific and cannot be mass-manufactured or sold in bulk. The prescribing clinician must hold an active DEA Schedule II registration in Louisiana. Some 503A compounding pharmacies in Louisiana offer mixed amphetamine salts capsules at or near $0 out-of-pocket as part of a telehealth bundled service, though that varies considerably by provider.

503B outsourcing facilities, which can compound larger quantities for office use, are not permitted to compound Schedule II stimulants for individual patient use under current DEA interpretation, so the 503A route is the only legal compounding pathway for this drug class in Louisiana. [4]

The FDA's guidance on compounding distinguishes clearly between the two sections: "Section 503A of the FD&C Act describes the conditions under which human drug products compounded by a licensed pharmacist or physician are exempt from certain provisions of the FD&C Act." [4]

Which Insurance Plans Cover Adderall XR in Louisiana?

Most commercial insurance plans available in Louisiana cover generic mixed amphetamine salts XR at Tier 2 or Tier 3, meaning a co-pay somewhere between $20 and $60 per month depending on the plan's benefit design and deductible status. [5]

Plans sold through the Louisiana Health Insurance Marketplace (healthcare.gov) are required to cover mental health and substance use disorder services under parity rules derived from the Mental Health Parity and Addiction Equity Act, but ADHD pharmacotherapy falls under the pharmacy benefit rather than the mental health benefit, so formulary rules still apply.

Employer-sponsored plans in Louisiana typically follow national PBM formularies (Express Scripts, CVS Caremark, OptumRx). On all three of those formularies, generic mixed amphetamine salts XR typically sits at Tier 2 with a $30 to $45 co-pay after deductible. Before deductible, the patient pays the full negotiated rate, which can be $50 to $90 per month depending on the plan.

Key steps for Louisiana insurance coverage:

1. Ask your pharmacy to run the claim under your specific plan before assuming a price.
2. Request a formulary exception if the generic is listed non-preferred; prescribers can submit a letter of medical necessity.
3. Compare the insured co-pay to the GoodRx cash price. For generic mixed amphetamine salts XR, the cash price is sometimes lower than the insured co-pay, especially early in a plan year when deductibles reset.

Dr. Craig Surman, a Harvard Medical School ADHD researcher, has noted that "cost barriers to stimulant treatment are a significant driver of treatment gaps in adult ADHD," a concern that applies directly to Louisiana patients whose plans place mixed amphetamine salts on higher cost-sharing tiers. [6]

Can You Get Adderall XR via Telehealth in Louisiana?

Yes. Telehealth prescribing of Adderall XR is permitted in Louisiana as of 2026, though Schedule II prescribing via telemedicine is subject to specific requirements tied to the post-COVID regulatory environment. [7]

The DEA's temporary COVID-era telemedicine exemptions for Schedule II controlled substances, originally set to expire, have been extended in modified form through a proposed rule that allows telemedicine prescribing of Schedule II drugs when the provider conducts a real-time audio-visual encounter, completes a documented clinical assessment including ADHD symptom screening, and operates a platform registered with DEA for telemedicine prescribing. Louisiana has no additional state-level restrictions that go beyond the federal floor.

For Louisiana patients, this means a telehealth visit through a platform such as HealthRX or similar ADHD-focused services can result in a legitimate Schedule II electronic prescription sent to a Louisiana pharmacy, provided the platform and prescriber meet DEA requirements. The prescription must be transmitted electronically under Louisiana's electronic prescribing for controlled substances (EPCS) mandate, which has been in effect since 2020. [8]

Patients in rural parishes (parishes in Louisiana function as counties do in other states) such as Sabine, West Carroll, or Cameron face particular access barriers to in-person psychiatry, making the telehealth route especially relevant. According to the Louisiana Department of Health, approximately 40 of Louisiana's 64 parishes are designated Mental Health Professional Shortage Areas, which underscores why telemedicine access to ADHD care matters. [9]

What Are the Cheapest Ways to Get Adderall XR in Louisiana?

The lowest-cost options for Louisiana patients, in rough order, are: a 503A compounding pharmacy with a telehealth provider bundle (potentially $0 to $30), generic mixed amphetamine salts XR with a GoodRx or similar coupon ($18 to $25), and the standard cash-pay generic without a coupon ($30). [10]

Several specific strategies cut costs further:

Switch to a different dose strength with the same pill count. A 30-count supply of 20 mg generic capsules may be priced identically to 10 mg. If your clinician is comfortable with a once-daily 20 mg dose rather than twice-daily 10 mg, the pharmacy bill stays flat.

Use a manufacturer savings card. Teva offers a savings card for branded Adderall XR that can reduce out-of-pocket cost for commercially insured patients to $30 per month for up to 12 fills. This card is not valid for Medicaid or Medicare patients. [11]

Ask the pharmacist specifically about the 30-day cash price versus a 90-day supply. Some Louisiana pharmacies price a 90-day cash supply at roughly 2.2 times the 30-day price rather than 3 times, saving about 27% per dose over the year.

Pill-splitting is not appropriate for XR formulations. Extended-release capsules contain beads; splitting or crushing disrupts the release mechanism and changes the pharmacokinetic profile, so dose-titration should happen only under clinical supervision.

The AACE/ACE guidelines on ADHD pharmacotherapy note that stimulant medication adherence is strongly tied to affordability, particularly in lower-income populations. [12] Louisiana has the 5th-highest poverty rate in the United States (19.6% as of 2023 Census data), which makes cost-reduction strategies clinically relevant rather than merely transactional.

Generic Mixed Amphetamine Salts: Which Manufacturers Are Available in Louisiana?

Multiple FDA-approved generic manufacturers supply Louisiana pharmacies, including Teva, Lannett, Mallinckrodt, Alvogen, and Zydus. [13]

Generic availability varies week-to-week because of ongoing manufacturing constraints that have affected the stimulant supply chain since 2022. The FDA's drug shortage database lists current availability status for each manufacturer. When one generic is unavailable, pharmacies often substitute another, and the clinical profile across FDA-approved generics is considered equivalent because each must demonstrate bioequivalence to the reference product per FDA Orange Book standards. [14]

Patients who notice symptom differences between generics can ask their prescriber to note a specific manufacturer on the prescription, though Louisiana pharmacies are not legally obligated to honor manufacturer preferences for generics and may not stock the preferred product. Documenting the specific lot and manufacturer when a formulation works well is a practical step before refill.

How the Adderall XR Shortage Affects Louisiana Prices

The extended shortage of mixed amphetamine salts that began in late 2022 caused cash prices to spike temporarily and pushed some Louisiana patients toward non-preferred alternatives. As of early 2026, supply has largely normalized, and the $30 average cash price reflects a more competitive market with multiple generics actively shipping to Louisiana distributors. [15]

The DEA sets annual production quotas for Schedule II stimulants, and those quota decisions directly influence how much raw amphetamine salt manufacturers can process each year. In 2023, the DEA initially proposed lower quotas before revising them upward after significant clinical pushback. The American Academy of Pediatrics and American Psychiatric Association both submitted formal comments urging quota increases to address treatment gaps. [16]

Louisiana pharmacies in smaller markets, particularly in the northern parishes and the Atchafalaya Basin corridor, reported longer stockouts than urban centers, partly because large retail chains received priority allocation from distributors. Independent pharmacies in those areas sometimes charged $10 to $15 more per month during peak shortage periods.

Dosing Basics: What to Expect With Adderall XR

Adderall XR is FDA-approved for ADHD in patients aged 6 and older, and for narcolepsy in adults. [17] The extended-release capsule delivers approximately 50% of the dose immediately and 50% four hours later, mimicking a twice-daily immediate-release schedule in a single capsule.

Standard starting doses by age:

• Children ages 6 to 12: 5 mg to 10 mg once daily in the morning, titrated by 5 mg to 10 mg per week to effect, maximum 30 mg/day
• Adolescents ages 13 to 17: 10 mg once daily, maximum 20 mg/day per label though clinical practice often extends to 30 mg
• Adults: 20 mg once daily is the labeled starting dose; doses up to 60 mg/day are used off-label under close supervision

The MTA Study found that carefully titrated stimulant pharmacotherapy produced a 0.8 standard deviation improvement in teacher-rated ADHD symptoms at 14 months compared to community care, with effect sizes comparable to those seen in short-term trials. [1]

Capsules can be opened and the beads sprinkled on applesium (a small amount of applesauce) for patients who cannot swallow capsules. Beads must not be chewed or crushed.

Safety, Drug Interactions, and Louisiana Prescribing Rules

Adderall XR carries a black-box warning for high potential for abuse and dependence as a Schedule II controlled substance. [17] Louisiana requires prescribers to query the Louisiana Prescription Monitoring Program (PMP) before prescribing any Schedule II drug, with no exceptions for telehealth encounters.

Common drug interactions that Louisiana prescribers and patients should flag:

• MAO inhibitors: contraindicated; can cause hypertensive crisis
• Alkalinizing agents (sodium bicarbonate, certain antacids): increase amphetamine absorption and prolong effects
• Acidifying agents (ascorbic acid, ammonium chloride): reduce amphetamine blood levels
• SSRIs and SNRIs: potential for serotonin-related effects at high doses

Cardiovascular effects include increases in heart rate (average 3 to 6 bpm) and systolic blood pressure (average 2 to 4 mmHg) at therapeutic doses. The FDA label notes that prior to prescribing stimulants, clinicians should assess for family history of sudden cardiac death, structural cardiac abnormality, or serious arrhythmia. [17]

Louisiana does not require a separate state triplicate prescription form for Schedule II drugs; the EPCS system satisfies state requirements for both paper and electronic prescribing since 2020.